Interpace Diagnostics Group's total assets for Q3 2025 were $12.04M, a decrease of ― from the previous quarter. IDXG total liabilities were $12.33M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.